The involvement of TNF-α-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-β-stimulated human dendritic cells to tumor cells

Journal of Immunology

Volumn 166, Issue 9, 2001, Pages 5407-5415

  Liu, S ^a   Yu, Y ^a   Zhang, M ^a   Wang, W ^a   Cao, X ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CASPASE 3; CASPASE INHIBITOR; CD14 ANTIGEN; CD34 ANTIGEN; I KAPPA B; LIGAND; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; STEM CELL; TUMOR CELL; TUMOR CELL LINE; TUMOR IMMUNITY;

EID: 0035339858     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.9.5407     Document Type: Article

References (49)

1. The dendritic cells system and its role in immunogenicity
2. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity
3. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo
4. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo
5. + T cell help to elicit protective and therapeutic antitumor immunity
6. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells
7. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors
8. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
9. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
10. Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells
11. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function
12. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
13. Heat shock protein 70 induced during tumor cell killing induces Thl cytokines and targets immature dendritic cell precursors to enhance antigen uptake
14. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
15. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage
16. Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow
17. 2+-dependent mechanism
18. In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells
19. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
20. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic cell function
21. Signal transduction by DR3. A death domain-containing receptor related to TNFR-1 and CD95
22. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
23. LARD: A new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing
24. A novel domain within the 55 kd TNF receptor signals cell death
25. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family
26. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4+ T cell killing of target cells
27. TRAlL/Apo-2-ligand-induced apoptosis in human T cells
28. Apoptosis signaling by death receptors
29. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
30. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
31. Identification of two novel receptors for the cytotoxic ligand TRAIL
32. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway
33. The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
34. Inhibition of death receptor signals by cellular FLIP
35. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
36. Relation of INF-related apoptosis-induced ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma
37. Expression and function of TNF-related apoptosis-inducing ligand of murine activated NK cells
38. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL
39. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate
40. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor-α
41. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity
42. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity
43. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis
44. IFN-γ is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: A possible role for nitric oxide
45. + human marrow cells induced by interferon-7 and tumor necrosis-γ and potentiated cytokine mediated hemopoietic suppression in vitro
46. IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression
47. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice
48. Immunobiology of dendritic cells
49. The nature of the principal type I interferon-producing cells in human blood